Thomas Engellenner

Thomas Engellenner

Pepper Hamilton LLP

Contact  |  View Bio  |  RSS

Latest Publications

Share:

Myriad - One Year Later

The Supreme Court decision last year on June 13, 2013 in Association of Molecular Pathology v. Myriad Genetics may have been a watershed moment for the biotechnology industry. So far the effects have been hard to detect, but...more

6/23/2014 - Ambry Biotechnology DNA Genetic Materials Myriad v Ambry Patent-Eligible Subject Matter Patents Roslin SCOTUS Section 101 Stem cells USPTO

The Curious Case Of Human Gene Patents

The U.S. Supreme Court heard oral arguments last month in the matter of Association for Molecular Pathology v. Myriad Genetics, a curious case that does not bode well for America’s biotechnology industry and could overturn 30...more

5/22/2013 - ACLU AMP v Myriad DNA Free Trade Agreement Human Genes Myriad Oral Argument Patents SCOTUS USPTO

Top Ten Reasons To File Your Patent Applications Before March 16, 2013

The recently enacted America Invents Act (AIA) introduces major changes to the U.S. patent laws, with some significant provisions taking effect on March 16, 2013. These provisions provide several compelling reasons to file...more

2/4/2013 - America Invents Act Filing Deadlines First-to-File First-to-Invent Patent Applications Patent Reform Patents Post-Grant Review Prior Art Prior User

3 Results
|
View per page
Page: of 1